Refractory Cytomegalovirus DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation: When Should Genotypic Drug Resistance Testing Be Requested?
Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-018-0191-8
Full Text
Open PDFAbstract
Available in full text
Date
April 26, 2018
Authors
Publisher
Springer Science and Business Media LLC